157
Participants
Start Date
August 3, 2022
Primary Completion Date
December 10, 2024
Study Completion Date
December 31, 2025
Placebo
Placebo is administered single dose or multiple dose by IV or SC injection
KK4277
KK4277 is administered single dose or multiple dose by IV or SC injection
Ajou University Hospital, Suwon
Fujita Health University Hospital, Kutsukake
Japan Community Health care Organization Chukyo Hospital, Minami
Juntendo University Urayasu Hospital, Urayasu
Kyusyu University Hospital, Higashi
Kanazawa University Hospital, Kanazawa
Yokohama City University Medical Center, Minami
Kitasato University Hospital, Minami
National University Corporation Tohoku University Tohoku University Hospital, Aoba
Niigata University Medical & Dental Hospital, Chuo Ku
University of the Ryukyus Hospital, Ginowan
Saitama Medical University Hospital, Moriyama
Institute of Science Tokyo Hospital, Bunkyō-Ku
St. Luke's International Hospital, Chuo Ku
Showa Medical University East Hospital, Shinagawa-Ku
Keio University Hospital, Shinjuku-Ku
Japan Institute for Health Security National Center for Global Health and Medicine, Shinjuku-Ku
Medical Co. LTA Sumida Hospital, Sumida-ku
Fukushima Medical University Hospital, Fukushima
Nagasaki University Hospital, Nagasaki
Juntendo University Nerima Hospital, Tokyo
Wakayama Medical University Hospital, Wakayama
Seoul National University Hospital, Seoul
Kyowa Kirin Co., Ltd.
INDUSTRY